Aurobindo Pharma tumbles 4%, hits 52-week low as USFDA issues 6 observations - Economic Times

Following the development, Aurobindo Pharmas counter touched a 52-week low of Rs 581 on the BSE. The scrip had closed at Rs 603.05 on Tuesday.

NEW DELHI: Shares of Aurobindo Pharmaceuticals dropped 3.7 per cent to hit a 52-week low on Wednesday as the US Food and Drug Administration issued the drug major with six observations following an i… [+2012 chars]

full article...